Bill > HR7118

This bill, the Genomic Answers for Children’s Health Act of 2026, clarifies that the Medicaid program will cover whole genome sequencing and whole exome sequencing for children with specific medical needs. Whole genome sequencing involves determining the complete genetic makeup of an individual, while whole exome sequencing focuses on the protein-coding regions of the genome. This coverage is intended for children suspected of having genetic disorders, rare diseases, or health conditions of unknown origin, including congenital anomalies, developmental delays, or intellectual disabilities, and will be considered a primary diagnostic test. The bill also mandates that payments for these sequencing services be separate and not bundled with other medical services, and requires the Secretary of Health and Human Services to conduct outreach and education to ensure awareness and access to these services, as well as to report on implementation and outcomes. Additionally, the Comptroller General will report on the implementation of these changes, including any barriers to access, impacts on care, and recommendations for improvement. These provisions are set to take effect on January 1, 2027.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/7118/all-info